Enhancement of 131I-mediated cytotoxicity by caffeine

Gynecologic Oncology
L L AndersonA I Kassis

Abstract

In cell culture, caffeine has been shown to enhance the lethality of DNA-damaging agents including ultraviolet rays, X-irradiation, and alkylating agents. We have previously reported a Phase I clinical trial demonstrating the feasibility of intraperitoneal radioimmunotherapy in patients with refractory ovarian cancer using 131I-labeled monoclonal antibody OC125. We are now exploring the possibility of using caffeine to enhance the toxicity of 131I-irradiation in target cells. As an in vitro model we tested this hypothesis using Chinese hamster ovary (CHO) cells exposed to 131I-labeled human serum albumin at various doses (4 to 70 microCi/ml) for 24 hr followed by 24 hr of incubation with caffeine. Cytotoxicity was measured by clonogenic survival and a nuclear fragmentation assay. The results show that caffeine, at a concentration of 7.7 mM, significantly enhances the cytotoxicity of 131I-irradiation.

References

Jan 1, 1978·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·N L OleinickR C Rustad
Sep 1, 1977·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·M H SnyderD B Leeper
Sep 1, 1979·Obstetrical & Gynecological Survey·N B RosensheinG Vogelsang
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J KuerbitzM B Kastan
Mar 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E Schneider-GädickeR C Knapp
Apr 1, 1989·European Journal of Cancer & Clinical Oncology·P O MulderN H Mulder
Nov 3, 1989·Science·L H Hartwell, T A Weinert
Sep 1, 1989·Gynecologic Oncology·N J FinklerR C Knapp
May 1, 1987·American Journal of Obstetrics and Gynecology·J T SoperW T Creasman
Jul 1, 1985·Gynecologic Oncology·Y N BakriA B Frazier
Jul 15, 1985·American Journal of Obstetrics and Gynecology·L R SmirzC E Ehrlich
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C C Lau, A B Pardee
Dec 1, 1982·Gynecologic Oncology·M J WebbD G Decker
Dec 16, 1994·Science·L H Hartwell, M B Kastan
Sep 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D J HonessN M Bleehen

❮ Previous
Next ❯

Citations

Aug 20, 2003·Nutrition and Cancer·Marc T GoodmanTimothy A Donlon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.